R. Shi

KuLGaP: A Selective Measure for Assessing Therapy Response in Patient-Derived Xenografts

A. Goldenberg, Ladislav Rampášek, B. Haibe-Kains, 2020, bioRxiv.

BRAF V600E mutation and MET amplification as resistance pathways of the second-generation anaplastic lymphoma kinase (ALK) inhibitor alectinib in lung cancer.

M. Tsao, O. Ludkovski, F. Shepherd, 2020, Lung cancer.

Organoid Cultures as Preclinical Models of Non–Small Cell Lung Cancer

B. Haibe-Kains, M. Tsao, Ni Liu, 2019, Clinical Cancer Research.

Targeting the CDK4/6-Rb Pathway Enhances Response to PI3K Inhibition in PIK3CA-Mutant Lung Squamous Cell Carcinoma

M. Tsao, F. Shepherd, N. Moghal, 2018, Clinical Cancer Research.

EGFR-mutated lung adenocarcinomas from patients who progressed on EGFR-inhibitors show high engraftment rates in xenograft models.

M. Tsao, F. Shepherd, N. Moghal, 2020, Lung cancer.

Abstract B32: Fidelity of genomic and proteomic features of patient-derived xenografts of lung cancers

M. Moran, Lei Li, M. Tsao, 2016 .

An Anaplastic Lymphoma Kinase Immunohistochemistry–Negative but Fluorescence In Situ Hybridization–Positive Lung Adenocarcinoma Is Resistant to Crizotinib

T. Pugh, M. Tsao, M. Varella‐Garcia, 2016, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

Assessing therapy response in patient-derived xenografts

A. Goldenberg, Ladislav Rampášek, Benjamin Haibe-Kains, 2021, Science Translational Medicine.

The effects of fluid shear stress on proliferation and osteogenesis of human periodontal ligament cells.

Y. Huang, Wei Song, Meili Liu, 2016, Journal of biomechanics.